We focused on the study of the maternal embryonic leucine zipper kinase (MELK) by analyzing 32 samples (12 control samples, 20 cervical cancer samples) using the Illumina HumanHT-12 V4.0 expression bead chip microarray platform 5. This evidence concerns the gene MELK and cervical carcinoma.